Developing the future of fungal diagnostics
Invasive fungal infections
A major cause for concern
Resistance to antifungal medication is becoming an important clinical problem, which threatens to undo many of the health advances of the last 50 years1. In the last 20 years, there has been little change in how clinicians diagnose fungal infections. This has led to inappropriate prescribing of antifungal medication and increased medical costs.2 New strategies are desperately required to better treat and diagnose life-threatening fungal infections. The fungal pathogens that pose the most risk are Candida, Aspergillus, Pneumocystis and Cryptococcus spp.3
The global view
In the developing world, diagnostic tests for fungal diseases are often not done or not available. Doctors therefore treat blind, if at all, leading to high infection rates.4
In the UK
A lack of a standardised diagnostic approach, means infections are commonly being misdiagnosed.5 This is leading to patients being prescribed inappropriate treatments.
Are we effectively treating fungal infections?
Why choose OLM Diagnostics?
A diagnostic-led approach
At OLM Diagnostics we are acting to address the threat of antifungal resistance. We are discovering and developing a new diagnostic-led approach to tackling fungal infections. Our research and development drives our company focus; to reinforce our reputation as a trusted healthcare partner and to enhance patient health outcomes.
Clinicians can have confidence in the sensitivity and specificity of our tests – to correctly identify true positive and true negative cases.
OLM Diagnostics aim to
The benefits of our tests
Our tests are inexpensive and require no additional laboratory equipment. They offer potential cost savings for hospitals; avoiding unnecessary prescriptions and higher costs associated with treating resistant infections. Some of these benefits include:
A reduced rate of drug resistant infections
Preservation of existing antifungal medication
Improvement to patient care through appropriate prescribing
Potential cost savings to the NHS and healthcare institutions
No extra costs or equipment required to run the diagnostic tests. Lab equipment already in place e.g. a PCR machine
Current diagnostic testing is poor, unreliable and time consuming. OLM Diagnostics offers an easy solution that allows clinicians to rapidly identify the exact cause of a patient’s infection
The OLM fungal diagnostic range
The AspDx range offers the ability to detect Aspergillus species, aiding in rapid and comprehensive diagnosis.
The CandDx range offers the ability to detect Candida species, aiding the clinician in a more accurate diagnosis and treatment approach.
PneumDx offers the ability to detect Pneumocystis jirovecii, a common cause of pneumonia and other respiratory infections.
Join our diagnostic-led approach
We know that many of the best ideas can come from collaboration. We are therefore committed to working with partners to deliver innovative new products.
Reduced drug resistance
Preservation of existing medication
Improved patient care
Potential cost savings
Lab equipment in place
